Back to company

Scanbio Denmark ApS: Financial statements 2022

CVR: 42107654

Scanbio Denmark ApS (CVR 42107654) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 8,062,158 and a net result of DKK 3,884,563 compared with DKK 447,682 the year before. That is an increase of 224.5% compared with the year before. Equity amounted to DKK 4,372,245. The solvency ratio was 15.3%. The company had 4 employees in the financial year.

Gross Profit
8,062,158 kr.
Profit/Loss
3,884,563 kr.
Equity
4,372,245 kr.
Total Assets
28,500,314 kr.
Employees
4

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022-8.1 mio.3.9 mio.4.4 mio.4
2021-2.5 mio.448 t.488 t.3

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on Scanbio Denmark ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

Scanbio Denmark ApS publishes interim reportAug 15, 2022

Scanbio Denmark ApS has published its interim report for the period February 8, 2021 – December 31, 2021.

About Scanbio Denmark ApS

Scanbio Denmark ApS is a Danish company of the type Anpartsselskab based in Nexø, founded in 2021. The company is registered under the industry Forarbejdning og konservering af fisk, krebsdyr og bløddyr, undtagen fiskemel. The management consists of Tor Vikenes. The company is owned by Scanbio Ingredients AS. In 2025, the company reported a gross profit of DKK 5,295,465 and a net result of DKK -135,927 compared with DKK 1,999,265 the year before. Equity amounted to DKK 10,249,140.

Other financial years